Scientific paperOutcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001
Section snippets
Patients
The BC Cancer Agency (BCCA) is a provincial organization with a broad-based mandate including all elements of cancer control [21]. The BCCA maintains a province-wide electronic database of cancer records for patients assessed or treated at the BCCA. The database contains prospectively collected demographic, prognostic, treatment, and outcome information. From this database patients with breast cancer who had one or more SNB were identified. In addition, 29 surgeons from 12 hospitals were
Results
Between October 1996 and July 2001, 29 surgeons in 12 hospitals performed 547 lymphatic mapping procedures and SNB in 540 women (7 with bilateral procedures) in British Columbia. The mean number of SNB per surgeon was 19 (range 1 to 80). The numbers of surgeons who performed 1 to 10, 11 to 20, 21 to 30, and greater than 30 procedures were 14 (48%), 6 (21%), 5 (17%), and 4 (14%), respectively.
Comments
Cancer control in the province of BC is characterized by a broad government-appointed mandate including all elements of cancer control for the province [21]. These include the development and dissemination of consensus practice guidelines about the full spectrum of cancer care, and coordination of cancer treatment services. A multidisciplinary group comprising both BCCA and community physicians and surgeons regularly review and publish recommendations for cancer management, including breast
References (48)
- et al.
Meta-analysis of sentinel lymph node biopsy in breast cancer
J Am Stat Soc
(1999) Sentinel lymphadenectomy in breast cancer. University research tool or community practice?
Surg Clin North Am
(2000)- et al.
National practice patterns of sentinel lymph node dissection for breast carcinoma
J Am Coll Surg
(2001) - et al.
Evaluation of feasibility and accuracy of sentinel node biopsy in early breast cancer
Am J Surg
(2001) - et al.
Learning sentinel node biopsyresults of a prospective randomized trial of two techniques
Surgery
(1999) - et al.
Sentinel lymph node biopsy in breast cancerinitial experience at Memorial Sloan-Kettering Cancer Center
J Am Coll Surg
(1998) - et al.
Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes
Lancet
(1997) The learning curve and sentinel node biopsy
Am J Surg
(2001)- et al.
Clinical practice guidelines for the care and treatment of breast cancer13. Sentinel lymph node biopsy
Can Med Assoc J
(2001) Clinical practice guidelines for the care and treatment of breast cancer4. Axillary dissection
Can Med Assoc J
(1998)
Clinical practice guidelines for the management of early breast cancer
Treatment of early stage breast cancer
JAMA
Lymphatic mapping and sentinel lymphadenectomy for breast cancer
Ann Surg
Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
JAMA
Sentinel lymphadenectomy in breast cancer
J Clin Oncol
The sentinel node in breast cancera multicentre study
N Engl J Med
Sentinel lymph node biopsy and axillary dissection in breast cancerresults in a large series
J Natl Cancer Inst
Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer
CA Cancer J Clin
The role of selective sentinel lymph node dissection in breast cancer
Surg Clin North Am
Sentinel node biopsy is not an alternative to axillary dissection in breast cancer
J Surg Oncol
Credentialing for breast lymphatic mappinghow many cases are enough?
Ann Surg
Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients
J Surg Oncol
Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients
J Surg Oncol
The credentialing of American surgery
Ann Surg Oncol
Cited by (29)
The role of sentinel lymph node biopsy in early-stage cervical cancer: A systematic review
2018, Taiwanese Journal of Obstetrics and GynecologyManagement of axilla in breast cancer - The saga continues
2015, BreastCitation Excerpt :This debate leads to the question whether the size of primary tumor impacts the rate of false negative SLNB? Several studies support the notion that the probability of false negative SLNB increases as the primary tumor size increases (Table 3) [23,25,41–45]. Only 2 of these studies [23,25] met the inclusion criteria for this review; 5 were excluded due to small numbers or inadequate reporting of data.
Intrauterine insemination versus fallopian tube sperm perfusion in non-tubal infertility
2012, Medical Journal Armed Forces IndiaCitation Excerpt :Although the number of available oocytes can be increased by ovarian stimulation, the pregnancy rates in IUI are still not promising, mainly because of suboptimal spermatozoa at the site of fertilization.2 An alternative procedure, termed Fallopian tube sperm perfusion (FSP), has been reported with improved pregnancy rates in comparison with IUI.3–5 In FSP sperm preparation is identical to the used with IUI, but the spermatozoa are diluted in a larger volume of medium up to 4 ml.6
Value of sentinel lymph node procedure in endometrial cancer
2007, Gynecologie Obstetrique et FertiliteMeasuring surgeon performance of sentinel lymph node biopsy in breast cancer treatment by cumulative sum analysis
2007, American Journal of SurgeryCitation Excerpt :The surgeons had established their SLN mapping techniques by participating in a training course followed by mentoring or were taught during residency. Surgeons participating in the training course had previously established acceptable performance [15, 16]. Informed consent for SLNB was obtained from all patients.